Pharmaceutical

Bristol Myers Squibb reports 6% drop in Q2 2023 revenues

Bristol Myers Squibb has reported revenues of $11.2bn in the second quarter of 2023, versus $11.8bn in Q2 2022, indicating a drop of 6%.

Jul 29, 2023 - 20:00
Bristol Myers Squibb reports 6% drop in Q2 2023 revenues
Bristol Myers Squibb has reported revenues of $11.2bn in the second quarter of 2023, versus $11.8bn in Q2 2022, indicating a drop of 6%.
Read the original article

Tags:

Previous Article

Carmell to merge with regenerative medicine company Axolotl

Next Article

InSilicoTrials and Axoltis to develop drugs for neurological disorders

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pear’s shadow effect: Data from a Medicaid digital health experiment does the policy rounds

STAT+: Pear’s shadow effect: Data from a Medicaid digit...

Sep 20, 2023

Gilead urged to improve access to HIV drug by public figures and celebrities

Gilead urged to improve access to HIV drug by public fi...

May 31, 2024

Opinion: Proposed rules to protect health data in an era of abortion bans fall short

Opinion: Proposed rules to protect health data in an er...

May 13, 2023